News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hagen Kennecke: First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer
Photo of Hagen Kennecke from ohsu.edu
Jul 10, 2024, 15:30

Hagen Kennecke: First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer

Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared a post on X:

”First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer, OS HR=0.4.

Patients are asking: do we recommend COX-2 for the 20% with mutation PIK3CA? 

Need to do NGS for all stage III CRC.”

Source: Hagen Kennecke/X

Anthony F Shields Ardaman Shergill Benjamin Tan cancer Chao Ma Charles S Fuchs Colon cancer Eileen M. O'Reilly Felix Couture Hagen Kennecke James Knight Jeffrey A Meyerhardt Jonathan A Nowak Juha Väyrynen Kenji Fujiyoshi Koichiro Haruki Melissa Zhao OncoDaily Oncology Pankaj Kumar Philip Kuebler Philip Philip Qian Shi Shrikant Mane Shuji Ogino Smitha Krishnamurthi Tyler Twombly
Special Coverage
Science
Dec 21, 2024, 13:12
Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski
Blog
Dec 21, 2024, 13:06
Varsha Gupta: Fertility preservation causes no significant delay in cancer treatment initiation and outcomes
Cancer Types
Dec 21, 2024, 13:05
Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment
Insight
Dec 21, 2024, 12:45
Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer
Insight
Dec 21, 2024, 12:39
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story